| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 03/06/2002 | EP1183015A1 Multilayered tablet for administration of a fixed combination of tramadol and diclofenac |
| 03/06/2002 | EP1183014A1 Controlled release and taste masking oral pharmaceutical compositions |
| 03/06/2002 | EP1183013A2 Melt granulation |
| 03/06/2002 | EP1183012A1 Novel formulations comprising lipid-regulating agents |
| 03/06/2002 | EP1183011A1 Method of treating angina and/or anginal equivalents, and pharmaceutical compositions and kit related thereto |
| 03/06/2002 | EP1183010A2 Implantable gel compositions and method of manufacture |
| 03/06/2002 | EP1182927A1 Antimicrobial sanitizing lotion with skin protection properties |
| 03/06/2002 | EP1069891B1 Wettable microcapsules having ethylcellulose coated cores |
| 03/06/2002 | EP1032378B1 Use of a mixture of a diol and an alpha-hydroxy acid for the treatment of hyperkeratotic skin diseases |
| 03/06/2002 | EP0946150B1 Oral preparation containing at least one active pharmaceutical substance in a matrix capable of swelling in an aqueous medium |
| 03/06/2002 | EP0942743B1 Topical preparation for introducing peptidaceous pharmacons in living organisms |
| 03/06/2002 | EP0938505B1 Anti-endoglin monoclonal antibodies and their use in anti-angiogenesis therapy |
| 03/06/2002 | EP0896529B1 Estradiol and progesterone-based medicament |
| 03/06/2002 | EP0845999B1 Method for the production of tablets by pressing and tablets produced by the method |
| 03/06/2002 | EP0835105B1 Pharmaceutical amiodarone composition for parenteral delivery |
| 03/06/2002 | EP0825854B1 Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery |
| 03/06/2002 | EP0790822B1 Controlled release composition forming a reversed micellar (l2) structure or a normal micellar (l1) structure |
| 03/06/2002 | EP0785797B1 A pharmaceutical formulation comprising a growth hormone and leucine |
| 03/06/2002 | EP0754045B1 compositions comprising halofantrine in a special form |
| 03/06/2002 | EP0734257B1 Pharmaceutical compositions for topical use containing (s)-2-(4-isobutylphenyl)propionic acid |
| 03/06/2002 | EP0710110B1 Antibodies of ring opened rapamycins |
| 03/06/2002 | CN1339068A Use of the cell's own transport system for transferring nucleic acids across the nuclear membrane |
| 03/06/2002 | CN1338956A Compressed air inhaler for pulmonary application of liposomal powder aerosols and powder aerosols suitable therefor |
| 03/06/2002 | CN1338947A Novel mucosal delivery system |
| 03/06/2002 | CN1338942A Self-emulsifying compositions for drugs poorly soluble in water |
| 03/06/2002 | CN1338940A Bidifobacterium in the treatment of inflammatory disease |
| 03/06/2002 | CN1338939A Compositions for the treatment of male erectile dysfunction |
| 03/06/2002 | CN1338933A Methods and compositions to enhance white blood cell count |
| 03/06/2002 | CN1338928A Combinations of formoterol and a tiotropium salt |
| 03/06/2002 | CN1338926A 可食用的包衣组合物 Edible coating composition |
| 03/06/2002 | CN1338925A Enteric coated pharmaceutical tablet and method of manufacturing |
| 03/06/2002 | CN1338924A Polymeric delivery agents and delivery agent compounds |
| 03/06/2002 | CN1338923A Method for controlling liposome size |
| 03/06/2002 | CN1338922A Use of nanoscale chitosanes and/or chitosane derivatives |
| 03/06/2002 | CN1080126C X-ray contrast medium used for checking of large and small intestine |
| 03/06/2002 | CN1080124C Pneumococcal polysaccharide conjugate vaccine |
| 03/06/2002 | CN1080123C Prolonged delivery of peptides |
| 03/06/2002 | CN1080120C Pharmaceutical compositions |
| 03/06/2002 | CN1080119C Pharmaceutical composition contg. proton pump inhibitors |
| 03/06/2002 | CN1080115C Elemi olefine injecta and its preparation |
| 03/06/2002 | CN1080114C Power formulations containing melezitose as diluent |
| 03/06/2002 | CN1080113C Oral gel capsule formulation of 1,2,4-benzotriazine oxides |
| 03/05/2002 | US6353124 Nonsteroidal antiinflammatory agents (aspirin, indomethacin, or ibuprofen) linked by tris amine or ethanolamine derivative to the acyl groups of fatty acids; improved transdermal delivery |
| 03/05/2002 | US6353055 Polycation homopolymer or copolymer |
| 03/05/2002 | US6353034 Fatty alcohols with polyglycosides |
| 03/05/2002 | US6353029 Storage stable tretinoin and 4-hydroxyanisole containing topical composition |
| 03/05/2002 | US6353022 Compositions containing hydroxyeicosatetraenoic acid derivatives and methods of use in treating dry eye disorders |
| 03/05/2002 | US6352998 A topical composition of a compound of the fk506 class in an alkanediol, ether diol, or diether alcohol solvent, an unsaturated fatty alcohol and water used as an antiinflammatory and antihyperproliferative for skin diseases |
| 03/05/2002 | US6352978 Pharmaceutical compositions containing tobramycin and xanthan gum |
| 03/05/2002 | US6352974 Oral calcitonin pharmaceutical compositions and methods of making the same |
| 03/05/2002 | US6352831 Glycolipid complexes and their uses |
| 03/05/2002 | US6352722 Time-release agent comprising trehalose diisobutyrate hexaacetate and fluticasone; drug delivery |
| 03/05/2002 | US6352720 Tablet with extra-granular disintegrant; administering orally to treat bacterial infections |
| 03/05/2002 | US6352719 Multilayer of hydroxypropyl methyl cellulose seal, adhesion promoting propylene glycol alginate, and sodium alginate barrier |
| 03/05/2002 | US6352717 Process for encapsulating shear sensitive fill masses into capsules and capsules containing shear sensitive fill masses |
| 03/05/2002 | US6352711 Mucoadhesive comprising microbiocide, dexamethasone, and diphenhydramine; analgesic, antihistamine, and antiinflammatory agents; secondary infection prevention |
| 03/05/2002 | US6352709 Introducing into patient a medical device of which at least a portion comprises one of a sydnonimine and a furoxan; anticoagulants |
| 03/05/2002 | US6352707 Comprising gelatin, dextran, nitric oxide inhibitor, and arginine, lysine, histidine, glutamic acid, or aspartic acid |
| 03/05/2002 | US6352697 Immunostimulating complex matrices; quil a fractions |
| 03/05/2002 | US6352683 Apparatus and method for the local delivery of drugs |
| 03/05/2002 | US6352682 Polymeric delivery of radionuclides and radiopharmaceuticals |
| 03/05/2002 | CA2191971C Pegylation reagents and compounds formed therewith |
| 03/05/2002 | CA2081269C Penetration enhancement of topically applied formulations |
| 03/05/2002 | CA2051531C Superior tasting pharmaceutical composition having porous particles and the process of preparing such pharmaceutical composition |
| 02/28/2002 | WO2002016611A2 Interleukin-22 polypeptides, nucleic acids encoding the same and methods for the treatment of pancreatic disorders |
| 02/28/2002 | WO2002016602A2 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | WO2002016581A2 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | WO2002016553A2 Regulator gene and system useful for the diagnosis and therapy of osteoporosis |
| 02/28/2002 | WO2002016429A2 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | WO2002016382A1 Improved specificity in treatment of diseases |
| 02/28/2002 | WO2002016368A1 Process for the preparation and purification of thiol-containing maytansinoids |
| 02/28/2002 | WO2002016333A2 Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease |
| 02/28/2002 | WO2002016309A1 Compounds and compositions for delivering active agents |
| 02/28/2002 | WO2002015959A2 Compounds and compositions for delivering active agents |
| 02/28/2002 | WO2002015940A2 Solution of an oxazolidinone antibiotic drug |
| 02/28/2002 | WO2002015939A2 Calycins |
| 02/28/2002 | WO2002015938A2 Testosterone ester formulation for human use |
| 02/28/2002 | WO2002015937A2 Pharmaceutical composition for the systematic administration of pharmacologically active ingredients containing polyol fatty acid esters |
| 02/28/2002 | WO2002015936A1 Antifungal ketoconazole composition for topical use |
| 02/28/2002 | WO2002015926A1 c-mpl LIGAND-CONTAINING MEDICINAL COMPOSITIONS FOR INCREASING PLATELETS AND ERYTHROCYTES |
| 02/28/2002 | WO2002015908A1 Injections |
| 02/28/2002 | WO2002015906A1 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon |
| 02/28/2002 | WO2002015903A2 Novel pharmaceutical composition for administering n-0923 |
| 02/28/2002 | WO2002015890A1 Transdermal therapeutic system |
| 02/28/2002 | WO2002015889A1 Transdermal therapeutic system for treating restless-legs-syndrome |
| 02/28/2002 | WO2002015887A1 Consumable container |
| 02/28/2002 | WO2002015886A2 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor |
| 02/28/2002 | WO2002015885A2 Oral fast-melt formulation of a cyclooxygenase-2 inhibitor |
| 02/28/2002 | WO2002015884A2 Rapidly disintegrating oral formulation of a cyclooxygenase-2 inhibitor |
| 02/28/2002 | WO2002015882A1 Delayed release compositions and combinations |
| 02/28/2002 | WO2002015881A2 Use of a porous carrier |
| 02/28/2002 | WO2002015880A2 Powdered mannitol and mannitol-containing compositions |
| 02/28/2002 | WO2002015878A1 Aqueous suspension preparations |
| 02/28/2002 | WO2002015876A2 Amorphous carrier materials for drug delivery |
| 02/28/2002 | WO2002015871A1 Use of tyramine in cosmetic compositions to lighten the skin |
| 02/28/2002 | WO2002015863A1 Dermatological composition |
| 02/28/2002 | WO2002015851A2 Storage stable tretinoin and 4-hydroxy anisole containing topical composition |
| 02/28/2002 | WO2002015844A2 Antimicrobial composition and methods of use in the treatment of disease |
| 02/28/2002 | WO2002015703A1 A release composition and method of preparation |
| 02/28/2002 | WO2002015702A1 A thermo-stable bio-matrix |